These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 22846408)

  • 1. Protein based tablets as reversible gelling systems for delayed release applications.
    Caillard R; Subirade M
    Int J Pharm; 2012 Nov; 437(1-2):130-6. PubMed ID: 22846408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-Lactoglobulin tablets as a suitable vehicle for protection and intestinal delivery of probiotic bacteria.
    Poulin JF; Caillard R; Subirade M
    Int J Pharm; 2011 Feb; 405(1-2):47-54. PubMed ID: 21129464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study on maize proteins as a potential new tablet excipient.
    Georget DM; Barker SA; Belton PS
    Eur J Pharm Biopharm; 2008 Jun; 69(2):718-26. PubMed ID: 18294824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular differences in the formation and structure of fine-stranded and particulate beta-lactoglobulin gels.
    Lefèvre T; Subirade M
    Biopolymers; 2000 Dec; 54(7):578-86. PubMed ID: 10984409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiscale characterization of individualized beta-lactoglobulin microgels formed upon heat treatment under narrow pH range conditions.
    Schmitt C; Bovay C; Vuilliomenet AM; Rouvet M; Bovetto L; Barbar R; Sanchez C
    Langmuir; 2009 Jul; 25(14):7899-909. PubMed ID: 19594178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified guar gum matrix tablet for controlled release of diltiazem hydrochloride.
    Toti US; Aminabhavi TM
    J Control Release; 2004 Mar; 95(3):567-77. PubMed ID: 15023467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carboxymethyl high amylose starch as excipient for controlled drug release: mechanistic study and the influence of degree of substitution.
    Lemieux M; Gosselin P; Mateescu MA
    Int J Pharm; 2009 Dec; 382(1-2):172-82. PubMed ID: 19716866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two- and three-layer tablet drug delivery systems for oral sustained release of soluble and poorly soluble drugs.
    Efentakis M; Naseef H; Vlachou M
    Drug Dev Ind Pharm; 2010 Aug; 36(8):903-16. PubMed ID: 20196641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of delayed-release proliposomes tablets for oral protein drug delivery.
    Tantisripreecha C; Jaturanpinyo M; Panyarachun B; Sarisuta N
    Drug Dev Ind Pharm; 2012 Jun; 38(6):718-27. PubMed ID: 21999514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel three-layered tablet for extended release with various layer formulations and in vitro release profiles.
    Park JS; Shim JY; Park JS; Choi YW; Jeong SH
    Drug Dev Ind Pharm; 2011 Jun; 37(6):664-72. PubMed ID: 21449708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and evaluation of succinylated soy protein tablets as delayed drug delivery systems.
    Caillard R; Petit A; Subirade M
    Int J Biol Macromol; 2009 Nov; 45(4):414-20. PubMed ID: 19576929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of protonation ratio on properties of carboxymethyl starch excipient at various substitution degrees: Structural insights and drug release kinetics.
    Assaad E; Mateescu MA
    Int J Pharm; 2010 Jul; 394(1-2):75-84. PubMed ID: 20435114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a matrix tablet prepared with polyacrylamide-g-sodium alginate co-polymers and their partially hydrolyzed co-polymers for sustained release of diltiazem hydrochloride.
    Mandal S; Ray R; Basu SK; Sa B
    J Biomater Sci Polym Ed; 2010; 21(13):1799-814. PubMed ID: 20557689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzymatic cross-linking of beta-lactoglobulin: conformational properties using FTIR spectroscopy.
    Eissa AS; Puhl C; Kadla JF; Khan SA
    Biomacromolecules; 2006 Jun; 7(6):1707-13. PubMed ID: 16768388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
    Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S
    Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation and evaluation of Ficus glomerata mucilage sustained release matrix tablets of gliclazide.
    Kumar CS; Reddy-Budideti KK; Battula SP; Ayyavala CS
    Pak J Pharm Sci; 2011 Jul; 24(3):399. PubMed ID: 21715275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro quantitative ((1))H and ((19))F nuclear magnetic resonance spectroscopy and imaging studies of fluvastatin™ in Lescol® XL tablets in a USP-IV dissolution cell.
    Zhang Q; Gladden L; Avalle P; Mantle M
    J Control Release; 2011 Dec; 156(3):345-54. PubMed ID: 21911016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and evaluation of natural gum-based sustained release matrix tablets of flurbiprofen using response surface methodology.
    Shah SN; Asghar S; Choudhry MA; Akash MS; ur Rehman N; Baksh S
    Drug Dev Ind Pharm; 2009 Dec; 35(12):1470-8. PubMed ID: 19929206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of pH-independent sustained release tablet containing solid dispersion granules of a poorly water-soluble drug.
    Tran HT; Park JB; Hong KH; Choi HG; Han HK; Lee J; Oh KT; Lee BJ
    Int J Pharm; 2011 Aug; 415(1-2):83-8. PubMed ID: 21641985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zero-order release of theophylline from a core-in-cup tablet in sequenced simulated gastric and intestinal fluid.
    Danckwerts MP; van der Watt JG; Moodley I
    Drug Dev Ind Pharm; 1998 Feb; 24(2):163-7. PubMed ID: 15605446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.